Eyebright Medical: The company plans to acquire no less than 51% of the equity in Delta Medical United (Chongqing) Medical Technology Co., Ltd. through a combination of acquisition loans and its own funds, thereby gaining control of Delta Medical. The company estimates that the overall valuation of the target company for this proposed acquisition will not exceed RMB 1 billion.

